On January 22, 2020, Bionik Laboratories Corp. entered into a Distribution Agreement with Curexo Inc., dated as of January 13, 2020. The Agreement replaces in its entirely and supersedes the Distribution Agreement between the Company and Curexo dated as of March 6, 2018 (the 2018 Agreement), which is terminated.

Pursuant to the Agreement, Curexo will act as the exclusive distributor of the Company's InMotion robotic systems in South Korea. There are no minimum purchase requirements of Curexo under the Agreement. The Company agreed to supply Curexo with three units of the InMotion Arm product at its own cost.

The term of the Agreement is for three years, and shall be automatically extended for successive one year terms, unless earlier terminated in accordance with the terms of the Agreement. Curexo shall indemnify the Company for any and all claims and damages for injury to or death of any person and for damage to or loss of property, arising out of or attributed to its conduct, operations or performance as distributor under the Agreement. As a result of the Agreement and the termination of the 2018 Agreement, the Company will no longer act as the exclusive distributor of Curexo's Morning Walk lower body rehabilitation technology (the Morning Walk) in the United States, and the Company has no further obligations to Curexo with respect to the Morning Walk.